Harnessing technology to map the rare disease patient journey continuum
Patient journey mapping is critical to understanding the real-world experience of rare disease patients and can inform pharma's commercial outlook and research programs.
Expanding digital health technologies transform patient journey mapping and unlock new insights.
So, what are the technologies that are making a difference?
How is technology being used to expedite rare disease diagnosis?
What is the role of natural language processing?
Turn to this report for the answers.
Companies
Takeda, Alexion, Huma, Orphalan
Subject synopsis
Research methodology and objectives
Key insights summary
Issues and insights
The importance of patient journey planning
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
Breadth and depth of AI use
Issue summary
Questions
Key insights
Supporting quotes
Use of large language models
Issue summary
Questions
Key insights
Supporting quotes
Challenges of AI use
Issue summary
Questions
Key insights
Supporting quotes
Tracking the everyday experience
Issue summary
Questions
Key insights
Supporting quotes
The challenge of small patient populations
Issue summary
Questions
Key insights
Supporting quotes
Partnering with patient advocates and groups
Issue summary
Questions
Key insights
Supporting quotes
Maximising whiteboard technology
Issue summary
Questions
Key insights
Supporting quotes
Applying technology to expedite diagnosis
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
Using technology to inform the natural history of disease